You are here

Article info

Article menu
Download PDFPDF
Review
The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancers

Authors

  • Anca Chelariu-Raicu Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Graziela Zibetti Dal Molin Department of Medical Oncology, A Beneficência Portuguesa de São Paulo e BP Mirante, São Paulo, Brazil PubMed articlesGoogle scholar articles
  • Robert L Coleman Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA The US Oncology Network, The Woodlands, Texas, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Robert L Coleman, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; rcoleman{at}gog.org
View Full Text

Citation

Chelariu-Raicu A, Zibetti Dal Molin G, Coleman RL
The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancers
International Journal of Gynecologic Cancer 2020;30:1608-1618.

Publication history

  • Received June 22, 2020
  • Revision received August 17, 2020
  • Accepted August 19, 2020
  • First published September 14, 2020.
Online issue publication 
January 08, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.